NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $504,819 | +14.2% | 4,956 | +13.1% | 0.01% | -77.6% |
| Q2 2023 | $442,087 | +9.7% | 4,381 | 0.0% | 0.06% | 0.0% |
| Q1 2023 | $403,052 | +1.4% | 4,381 | 0.0% | 0.06% | -4.9% |
| Q4 2022 | $397,444 | +19.4% | 4,381 | 0.0% | 0.06% | +10.9% |
| Q3 2022 | $333,000 | -10.0% | 4,381 | 0.0% | 0.06% | -6.8% |
| Q2 2022 | $370,000 | -3.6% | 4,381 | 0.0% | 0.06% | +18.0% |
| Q1 2022 | $384,000 | +14.6% | 4,381 | +14.4% | 0.05% | +13.6% |
| Q4 2021 | $335,000 | +7.0% | 3,831 | 0.0% | 0.04% | -2.2% |
| Q3 2021 | $313,000 | -10.6% | 3,831 | 0.0% | 0.04% | -10.0% |
| Q2 2021 | $350,000 | +28.2% | 3,831 | +20.1% | 0.05% | +13.6% |
| Q1 2021 | $273,000 | -15.2% | 3,191 | -6.3% | 0.04% | -4.3% |
| Q4 2020 | $322,000 | +43.1% | 3,406 | +31.6% | 0.05% | +24.3% |
| Q3 2020 | $225,000 | – | 2,588 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Newman Dignan & Sheerar, Inc. | 3,739 | $353,074,000 | 56.77% |
| Susquehanna International Securities, Ltd. | 118,837 | $11,222,000 | 8.15% |
| MANAGED ASSET PORTFOLIOS, LLC | 336,762 | $31,800,000 | 5.59% |
| Martin Investment Management, LLC | 169,019 | $15,960,000 | 5.10% |
| SCHARF INVESTMENTS, LLC | 1,197,539 | $113,083,000 | 4.26% |
| GARLAND CAPITAL MANAGEMENT INC | 50,705 | $4,788,000 | 4.06% |
| Mawer Investment Management Ltd. | 6,625,594 | $625,655,000 | 3.69% |
| SPHERA FUNDS MANAGEMENT LTD. | 429,000 | $40,510,000 | 3.60% |
| First Fiduciary Investment Counsel, Inc. | 196,693 | $18,574,000 | 3.48% |
| PROFESSIONAL ADVISORY SERVICES INC | 227,971 | $21,527,000 | 3.46% |